Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome (STOP TEVAR PIS): A Randomized, Double-Blind, Placebo-Controlled Trial

NCT07328906 is registered in ClinicalTrials.gov with University of Belgrade as lead sponsor.

NCT NCT07328906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07328906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome (STOP TEVAR PIS): A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
University of Belgrade
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
January 31, 2029
Enrollment
174 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mace, mortality, myocardial injury, postimplantation syndrome